COR 8-K 2026-11-04

Cencora, Inc. (COR) 8-K dated 2026-11-04 — accession 0001140859-26-000038.

Cencora, Inc. (COR) is a medical distribution company listed on NYSE.

COR: CENCORA REPORTS FISCAL 2026 FOURTH QUARTER AND FISCAL YEAR END RESULTS

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.55B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B.

Not investment advice. The COR SEC hub lists recent forms. The stock page is the research view.